COVAXIN Safe for Children Aged 2-18 Years: Bharat Biotech
GG News Bureau
New Delhi, 18th June. Bharat Biotech International Limited has announced that Covaxin, its whole-virion inactivated COVID-19 vaccine, has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in…